Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2006
05/26/2006WO2005047472A3 Increasing seed threonine content through alteration of threonine aldolase activity
05/26/2006WO2005014782A8 Double-stranded ribonucleic acid with increased effectiveness in an organism
05/26/2006WO2004108897A3 Sirna libraries
05/26/2006WO2004087878A3 Novel plant promoters for use in early seed development
05/26/2006WO2004081567A8 Organic substance immobilizing chip and its use
05/26/2006WO2004035765A3 Double-stranded rna structures and constructs, and methods for generating and using the same
05/26/2006WO2004024876A3 Polyhydroxyalkanoate production by coenzyme a-dependent aldehyde dehydrogenase pathways
05/26/2006WO2003100007A3 Eta-1 gene and methods for use
05/26/2006CA2838516A1 Treatment of disease
05/26/2006CA2588157A1 Cancer immunotherapy incorporating p53
05/26/2006CA2588066A1 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis
05/26/2006CA2588053A1 Method of diagnosing the risk of thermolabile phenotype diseases by using gene
05/26/2006CA2587948A1 Tnf antagonists
05/26/2006CA2587923A1 Genetic variant of the annexin a5 gene
05/26/2006CA2587798A1 Maize cr1bio gene promoter and its use to direct root-preferred transgene expression in plants
05/26/2006CA2587719A1 Method of screening compound regulating the translation of specific mrna
05/26/2006CA2587716A1 Hcv f protein and uses thereof
05/26/2006CA2587676A1 Improved treatment of cancer by double-stranded rna
05/26/2006CA2587627A1 Desacyl ghrelin antibodies and therapeutic uses thereof
05/26/2006CA2587411A1 Sirna silencing of apolipoprotein b
05/26/2006CA2587401A1 Casein kinase stress-related polypeptides and methods of use in plants
05/26/2006CA2586998A1 Structure-based compound design involving riboswitches
05/26/2006CA2586620A1 Multivalent vaccines comprising recombinant viral vectors
05/26/2006CA2586615A1 Pro87299 (btla), and variants thereof, for treating immune related disorders
05/26/2006CA2586331A1 Arabidopsis and brassica nucleic acid sequences conferring lipid and sugar alterations in plants and methods of use
05/26/2006CA2586241A1 Herbicide-resistance gene and utilization thereof
05/26/2006CA2585985A1 Methods of developing a stem cell line
05/26/2006CA2585308A1 A non-human animal alzheimer's disease model and uses thereof
05/26/2006CA2585178A1 High arachidonic acid producing strains of yarrowia lipolytica
05/26/2006CA2584222A1 Neutralising antibody molecules having specificity for human il-17
05/25/2006WO2006037038A9 Optimized vaccines to provide protection against ebola and other viruses
05/25/2006WO2006022947B1 Protein and nucleic acid sequence encoding a krill-derived cold adapted trypsin-like activity enzyme
05/25/2006WO2006009330A9 Compositions and methods of using a regulator of biopolymer production
05/25/2006US20060112454 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
05/25/2006US20060112453 Dietary proteins with improved nutritional quality and reduced or negative allergenicity for human and animal consumption through genetic engineering
05/25/2006US20060112452 Expression cassettes for seed-preferential expression in plants
05/25/2006US20060112451 Process for preparing ketocarotenoids in genetically modified organisms
05/25/2006US20060112449 Novel B-type gene from oil palm
05/25/2006US20060112448 Polynucleotides encoding enzymes involved in the modification of beta-amyrin during the biosynthesis of beta-amyrin-derived triterpenes in plants and seeds
05/25/2006US20060112447 Nucleotide sequences encoding cry1bb proteins for enhanced expression in plants
05/25/2006US20060112446 Transposon genes of rice, transformed plant and method of use
05/25/2006US20060112445 Novel regulatory regions
05/25/2006US20060112444 Inbred corn line PHAKC
05/25/2006US20060112443 increasing the weight percent of at least one amino acid essential to the diet of animals, or increasing the starch content of a plant; increased seed storage proteins; stably transforming cells of a plant with an expression cassette
05/25/2006US20060112442 genetic constructs comprising nucleotide sequences linked to heterologous sequences and transcription terminators, capable of driving and/or regulating gene expression; genetic vectors, host cells and transgenic plant cells
05/25/2006US20060112441 CYT28 serpentine receptor disruptions, compositions and methods relating thereto
05/25/2006US20060112439 Delta opioid receptor disruptions, compositions and methods related thereto
05/25/2006US20060112438 Novel culture systems for ex vivo development
05/25/2006US20060112437 Transgenic animal expressing alzheimer's tau protein
05/25/2006US20060111563 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer; one pot deprotection; solution phase synthesis; solid phase synthesis
05/25/2006US20060111562 Human SDF-5 protein and compositions
05/25/2006US20060111561 Novel proteins and nucleic acids encoded thereby
05/25/2006US20060111558 Recombinant infectious laryngotracheitis virus and uses thereof
05/25/2006US20060111556 Preventives/remedies for neurodegenerative diseases
05/25/2006US20060111315 Method for inhibition of pathogenic microorganisms
05/25/2006US20060111312 Antigene locks and therapeutic uses thereof
05/25/2006US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function
05/25/2006US20060111282 for treatment of blood coaggulation disorders; trauma
05/25/2006US20060111278 TFF peptides
05/25/2006US20060110829 Apparatus and system having dry gene silencing pools
05/25/2006US20060110827 nucleic acid encoding a phytochrome protein comprising a mutation in the P3 GAF domain; cyanobacterial phytochrome
05/25/2006US20060110823 Transgenic mice containing glucocorticoid-induced receptor gene disruptions
05/25/2006US20060110812 host cell transformation for bioethanol production from cellulostic feedstocks
05/25/2006US20060110810 Methods and materials for the synthesis of organic products
05/25/2006US20060110809 Methods for production of xylitol in microorganisms
05/25/2006US20060110806 Docosahexaenoic acid producing strains of Yarrowia lipolytica
05/25/2006US20060110801 Receptor for b. anthracis toxin
05/25/2006US20060110799 Mitogen-activated protein kinase kinase MEK6 and methods of use thereof
05/25/2006US20060110798 Cells expressing recombinase useful for adenovirus vector production and control of gene expression
05/25/2006US20060110796 In vivo site-specific incorporation of N-acetyl-galactosamine amino acids in eubacteria
05/25/2006US20060110795 use a glucosidase II mutation to increase glycoprotein biosynthesis from the fungus cell; yeast, Aspergillus, Fusarium, Geotrichum, Monascus, Monilia, Mucor, Penecillium, Rhizopus, Trichoderma and Ustilago; producing glucosidase, mannanase, biodrugs; host cells
05/25/2006US20060110791 large-scale production of functionally active enzyme trypanothione reductase of Leishmania donovani; amplification, purification
05/25/2006US20060110790 Expression system for large functional proteins
05/25/2006US20060110789 Methods to mediate polyketide synthase module effectiveness
05/25/2006US20060110788 Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
05/25/2006US20060110784 Site-specific labeling of proteins for NMR studies
05/25/2006US20060110777 Structured peptide scaffold for displaying turn libraries on phage
05/25/2006US20060110772 Human and murine cytokine polypeptides
05/25/2006US20060110771 Proteins capable of binding to female sex hormones and process for producing the same
05/25/2006US20060110770 Administering polypeptide of given sequence, which hydrolyzes DNA in sputum of cystic fibrosis patients
05/25/2006US20060110769 Regulation of novel human prolyl 4-hydroxylases
05/25/2006US20060110766 Method of determining a cellular response to a biological agent
05/25/2006US20060110761 Identification of a gene causing the most common form of Bardet-Biedl syndrome and uses thereof
05/25/2006US20060110757 Method of designing probe from polynucleotide group comprising plurality of polynucleotides
05/25/2006US20060110750 Structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations
05/25/2006US20060110747 Process for improved protein expression by strain engineering
05/25/2006US20060110746 Treatment of cancer using TLR3 agonists
05/25/2006US20060110745 Method for amplifying nucleic acids
05/25/2006US20060110739 Biosensors for detecting macromolecules and other analytes
05/25/2006US20060110737 Human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it
05/25/2006US20060110736 Hiv vaccine formulations
05/25/2006US20060110733 Coded nucleic acid carriers
05/25/2006US20060110730 Methods and compositions for regulation and manipulation of steroidogenesis
05/25/2006US20060110729 Method of dna testing for mycobacterium paratuberculosis strains
05/25/2006US20060110440 Method and system for biasing cellular development
05/25/2006US20060110437 Synthesis and self-assembly of abc triblock bola peptide
05/25/2006US20060110410 Recombinant toxin fragments
05/25/2006US20060110408 Immunological combination compositions and methods
05/25/2006US20060110403 Non-human herpesviruses as vectors
05/25/2006US20060110401 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof